Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator.

Dimaraki EV, Jaffe CA, Demott-Friberg R, Russell-Aulet M, Bowers CY, Marbach P, Barkan AL.

Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E489-95.

2.

Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin.

Dimaraki EV, Jaffe CA, Bowers CY, Marbach P, Barkan AL.

Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E163-70. Epub 2003 Apr 1.

3.

Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.

Veldhuis JD, Evans WS, Bowers CY.

J Clin Endocrinol Metab. 2002 Feb;87(2):859-66.

PMID:
11836333
6.

Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.

Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.

Clin Endocrinol (Oxf). 2002 Apr;56(4):487-92.

PMID:
11966741
7.

Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.

Renner U, Brockmeier S, Strasburger CJ, Lange M, Schopohl J, Müller OA, von Werder K, Stalla GK.

J Clin Endocrinol Metab. 1994 May;78(5):1090-6.

PMID:
8175966
8.

The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?

Riedel M, Günther T, von zur Mühlen A, Brabant G.

Clin Endocrinol (Oxf). 1992 Sep;37(3):233-9.

PMID:
1358484
10.

Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.

Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL.

J Clin Endocrinol Metab. 1993 Dec;77(6):1641-7.

PMID:
7903313
11.
12.

Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.

Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Feb;86(2):551-60.

PMID:
11158008
14.

Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.

Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.

J Clin Endocrinol Metab. 2000 Mar;85(3):1310-5.

PMID:
10720081
15.

Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.

degli Uberti EC, Ambrosio MR, Cella SG, Margutti AR, Trasforini G, Rigamonti AE, Petrone E, Müller EE.

J Clin Endocrinol Metab. 1997 Sep;82(9):2885-8.

PMID:
9284714
17.
18.

Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses.

Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frölich M, Stokvis-Brantsma WH, Wit JM.

J Clin Endocrinol Metab. 2001 Jun;86(6):2459-64.

PMID:
11397840
19.

Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.

Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA.

J Clin Endocrinol Metab. 1998 Apr;83(4):1186-9.

PMID:
9543138
20.

Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.

Villas-Boas Weffort RF, Ramos-Dias JC, Chipoch C, Lengyel AM.

Metabolism. 1997 Jun;46(6):706-10.

PMID:
9186309

Supplemental Content

Support Center